You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Locally recurrent

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Exploration of Locally Recurrent Colorectal Cancer

Recruiting
  • Locally Recurrent Colorectal Cancer
  • salvage surgery
  • Beijing, Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences & Peking Un
Oct 28, 2023

Rectal Cancer, Recurrent Trial in Shanghai (Carbon ion radiation therapy DT: 74Gy/20 fractions)

Not yet recruiting
  • Rectal Cancer
  • Recurrent
  • Carbon ion radiation therapy DT: 74Gy/20 fractions
  • Shanghai, Pudong, China
    Shanghai Proton and Heavy ion center
Apr 7, 2023

Lung Cancer Stage IV Trial in Maastricht (Radiation)

Not yet recruiting
  • Lung Cancer Stage IV
  • Radiation
  • Maastricht, Netherlands
    Maastricht Radiation Oncology (Maastro)
Aug 29, 2023

Recurrent Rectal Cancer Trial in Shanghai (PD-1 antibody, Capecitabine, Oxaliplatin)

Not yet recruiting
  • Recurrent Rectal Cancer
  • PD-1 antibody
  • +3 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 17, 2022

Breast Cancer, Recurrent Trial in Meldola (Partial breast re-irradiation)

Not yet recruiting
  • Breast Cancer
  • Recurrent
  • Partial breast re-irradiation
  • Meldola, Forlì Cesena, Italy
    UO Radioterapia, IRST IRCCS
Mar 6, 2023

Rectal Tumors, Tumor Recurrence, Local Trial

Completed
  • Rectal Neoplasms
  • Neoplasm Recurrence, Local
    • (no location specified)
    Jul 25, 2022

    Locally Advanced Rectal Cancer, Locally Recurrent Rectal Cancer Trial in Southampton (Intraoperative Electron Radiotherapy

    Recruiting
    • Locally Advanced Rectal Cancer
    • Locally Recurrent Rectal Cancer
    • Intraoperative Electron Radiotherapy (IOERT)
    • Extended Margin Surgery
    • Southampton, Hampshire, United Kingdom
      University Hospital Southampton NHS Foundation Trust
    May 24, 2023

    Cutaneous Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma of the Head and Neck Trial in Tucson, Tampa

    Terminated
    Has Results
    • Cutaneous Squamous Cell Carcinoma
    • Cutaneous Squamous Cell Carcinoma of the Head and Neck
    • Tucson, Arizona
    • +1 more
    Nov 2, 2022

    Prostate Cancer Recurrent Trial in Toronto (HDR brachytherapy)

    Active, not recruiting
    • Prostate Cancer Recurrent
    • HDR brachytherapy
    • Toronto, Ontario, Canada
      Odette Cancer Centre, Sunnybrook Health Sciences Centre
    May 3, 2022

    Recurrent Skin Squamous Cell Carcinoma, Resectable Skin Squamous Cell Carcinoma, Stage I Skin Cancer Trial in Los Angeles,

    Recruiting
    • Recurrent Skin Squamous Cell Carcinoma
    • +4 more
    • Cemiplimab
    • Resection
    • Los Angeles, California
    • +2 more
    Nov 12, 2022

    Rectal Adenocarcinoma, Recurrent Rectal Carcinoma, Stage IV Rectal Cancer AJCC v7 Trial in Scottsdale, Rochester (other,

    Completed
    • Rectal Adenocarcinoma
    • +4 more
    • Quality-of-Life Assessment
    • +2 more
    • Scottsdale, Arizona
    • +1 more
    Jan 3, 2023

    Triple Negative Breast Cancer (TNBC) Trial (Pembrolizumab, Nab-paclitaxel, Paclitaxel)

    Active, not recruiting
    Has Results
    • Triple Negative Breast Cancer (TNBC)
    • Pembrolizumab
    • +5 more
    • (no location specified)
    Jul 15, 2022

    Metastatic Breast Cancer Trial in Shanghai (Sitravatinib, Tislelizumab, Nab-paclitaxel)

    Recruiting
    • Metastatic Breast Cancer
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer
    Jul 31, 2022

    Prostate Cancer, Prosatatic Tumor Trial run by the National Cancer Institute (NCI) (18F-DCFPyL, Tumor Irradiation, Prostate +

    Recruiting
    • Prostate Cancer
    • Prosatatic Neoplasm
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Apr 7, 2022

    Locally Recurrent/Metastatic Triple Negative Breast Cancer Trial in United States (radiation, drug, procedure)

    Recruiting
    • Locally Recurrent/Metastatic Triple Negative Breast Cancer
    • external beam radiation therapy
    • +2 more
    • Basking Ridge, New Jersey
    • +6 more
    Aug 8, 2022

    Prostate Cancer Trial in Detroit (Ad5-yCD/mutTKSR39rep-hIL12)

    Active, not recruiting
    • Prostate Cancer
    • Ad5-yCD/mutTKSR39rep-hIL12
    • Detroit, Michigan
      Henry Ford Health System
    Feb 17, 2022

    Squamous Cell Carcinoma of the Head and Neck Trial in La Jolla, San Francisco, Torrance (Pembrolizumab)

    Active, not recruiting
    • Squamous Cell Carcinoma of the Head and Neck
    • La Jolla, California
    • +2 more
    Aug 17, 2022

    Recurrent Vulvar Cancer, Persistent Vulvar Cancer, Metastatic Vulva Cancer Trial (Pembrolizumab, Lenvatinib)

    Not yet recruiting
    • Recurrent Vulvar Cancer
    • +3 more
    • (no location specified)
    Jun 12, 2023

    GENE EXPRESSION PROFILING IN A VALIDATION COHORT OF LOCALLY

    Not yet recruiting
    • Salivary Gland Cancer
    • Observation
    • (no location specified)
    Oct 13, 2023

    Locally Advanced or Recurrent Metastatic HER-2 Negative Breast Cancer Trial in Shanghai (BL-B01D1, SI-B003)

    Not yet recruiting
    • Locally Advanced or Recurrent Metastatic HER-2 Negative Breast Cancer
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Sep 12, 2023

    Male Breast Cancer, Recurrent Melanoma, Stage IV Breast Cancer Trial in Columbus (propranolol HCl, Correlative Studies)

    Completed
    • Male Breast Cancer
    • +7 more
    • propranolol hydrochloride
    • Correlative Studies
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Dec 4, 2022

    Metastatic Breast Cancer Trial (SKB264, Eribulin, Capecitabine)

    Not yet recruiting
    • Metastatic Breast Cancer
    • (no location specified)
    Oct 7, 2023

    Head Neck Cancer, Squamous Cell Carcinoma Trial in Koriyama (Accelerator-based BNCT with borofalan(10B))

    Active, not recruiting
    • Head and Neck Cancer
    • Squamous Cell Carcinoma
    • Accelerator-based BNCT with borofalan(10B)
    • Koriyama, Fukushima, Japan
      Southern Tohoku BNCT Research Center
    Jun 2, 2023

    Triple Negative Breast Cancer, Metastatic Breast Cancer, Mutation Trial in Shanghai (Everolimus, Investigator's Choice of

    Not yet recruiting
    • Triple Negative Breast Cancer
    • +2 more
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Jul 25, 2023

    Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial in Houston (Best Practice, Educational Intervention,

    Recruiting
    • Metastatic Malignant Solid Neoplasm
    • Recurrent Malignant Solid Neoplasm
    • Best Practice
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 11, 2022